vimarsana.com
Home
Live Updates
Durvalumab With Chemotherapy Shows Long-Term Overall Surviva
Durvalumab With Chemotherapy Shows Long-Term Overall Surviva
Durvalumab With Chemotherapy Shows Long-Term Overall Survival at 3 Years
The results were the longest survival follow-up ever reported for a phase 3 trial for biliary tract cancer.
Related Keywords
China ,
Thailand ,
Seoul ,
Soult Ukpyolsi ,
South Korea ,
United States ,
Japan ,
Utah ,
American ,
America ,
Susan Galbraith ,
Astrazeneca ,
Cholangiocarcinoma Foundation Conference In Salt Lake City ,
Seoul National University College Of Medicine ,
American Cancer Society ,
Foundation Conference ,
Salt Lake City ,
Design Cells ,
Internal Medicine ,
Seoul National University Hospital ,
Seoul National University College ,
South America ,